Kinarus Therapeutics (SIX:KNRS)

About:

Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.

Website: https://www.kinarus.com/

Top Investors: Chaodian Culture, Yorkville Advisors

Description:

Kinarus is a biopharmaceutical company that develops differentiated medicines in areas of stress related inflammatory processes based on cross disease area target assessment.

Total Funding Amount:

36.6M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2017-09-01

Contact Email:

matthew.wright(AT)kinarus.com

Founders:

Alexander Bausch

Number of Employees:

1-10

Last Funding Date:

2023-05-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai